Niraj Kumar Jha is an expert in Biochemistry at Chitkara University (India). As of October 2026, ScienceLeadR ranks Niraj Kumar Jha in the top 1% of experts in India for Alzheimer Disease, Dementia and Neurocognitive Disorders. Niraj Kumar Jha has authored 345 publications, the most recent in 2026. SLR score: 898 (community average: 125). How the SLR is computed.

LeadR Profile

Niraj Kumar Jha Chitkara University India
898 ScienceLeadR Reputation 898
Network Map

Biochemistry

Subspecialties: Pharmacy - Neurology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dr. Niraj Kumar Jha is a member of the Royal Society of Biology, London. Currently, he is an assistant professor at the Department of Biotechnology, Sharda University, Greater Noida, India. He is a former assistant professor of the Faculty of Biotechnology, Noida Institute of Engineering and Technology (NIET), affiliated with Abdul Kalam Technical University (AKTU), India. He has an MSc in Biotechnology from Vellore Institute of Technology, Tamilnadu, India, and a Ph.D. in Biotechnology from Delhi Technological University with a research fellowship from the Department of Biotechnology, Government of India. He is a well-acknowledged author and researcher who has published over 150 quality scholarly works including original research, reviews, and book chapters in prestigious international journals. He has also presented his research work at prestigious international conferences and annual meetings of professional scientific associations. Currently, he is serving as an associate editor of IET Nanobiotechnology (Wiley) and guest editor of numerous peer-reviewed and referred international journals of high impact and reputation including Material Today Chemistry, Frontiers in Bioscience-Landmark, Antioxidants, Environmental Science and Pollution Research, and Biomolecules. He is an editorial board member of various high-repute international journals and assisted significantly in reviewing articles from many international journals such as Scientific Reports, Life Sciences, European Journal of Pharmaceutical Sciences, and Journal of Food Biochemistry. His research interests include understanding the pathogenesis of neurodegenerative, cancer, respiratory and cardiovascular diseases, and deciphering the therapeutic and preventive role of small molecules of natural or synthetic origin.

Organizations

Career arc: 2019 - 2026

Source: PubMed

Sharda University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 345

Citations

Citations: 10 559 1st author: 19 Last author: 43 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Tumor suppressor network dysregulation in neuroblastoma: molecular mechanisms and precision therapeutic opportunities.
PMID 42405329 — cells, genes, genes, suppressor, microscopy, electron, scanning transmission, neoplasms, therapeutics, mutation, neuroblastoma, genes, tumor suppressor
Front Cell Dev Biol20260
Correction: Barani et al. Nanomaterials in the Management of Gram-Negative Bacterial Infections. Nanomaterials 2021, 11, 2535.
PMID 42274710 — bacterial infections, nanostructures, gram-negative bacterial infections, infections
Nanomaterials (Basel)20260
Integrating Molecular Pathology, Tumor Microenvironment, and Novel Therapies to Overcome Resistance in Glioblastoma.
PMID 42257792 — promoter regions, genetic, molecular biology, brain, neoplasms, pathology, pathology, molecular, glioblastoma, neurosciences, therapeutics, tumor microenvironment
J Mol Neurosci20260
mTOR Signalling in Neurodegenerative Disorders: Unveiling Key Factors, Mechanistic Insights, and Possible Therapeutic Interventions.
PMID 42057546 — cells, therapeutics, neurodegenerative diseases
Cell Physiol Biochem20260
Microbiota-driven neuroimmune mechanisms in brain disorders: Microglial activation, cytokine signaling, and translational implications.
PMID 41886797 — cytokines, brain, neuroimmunomodulation, brain diseases, microbiota
J Neuroimmunol20260

LeadR Networks

Main global connection map